• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Alcon

Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment

May 23, 2022 By Sean Whooley

Alcon (NYSE:ACL) announced today that it agreed to acquire Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals. Geneva, Switzerland-based Alcon will pay $60 million upfront to Kala for the dry eye treatment. As part of the agreement, the company will also acquire Kala’s Inveltys corticosteroid for twice-per-day treatment of post-operative inflammation and pain following ocular surgery. Get the […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions, Optical/Ophthalmic, Pharmaceutical Tagged With: Alcon, Kala Pharmaceuticals

Alcon beats the Street with Q1 results

May 10, 2022 By Jim Hammerand

Alcon (SIX/NYSE:ALC) posted first quarter results today that beat the consensus forecast on Wall Street and maintained its sales and earnings outlook for the rest of the year. The Geneva, Switzerland–based eye care tech company reported profits of $168 million, or $0.34 per share, on sales of $2.2 billion for the three months ended March […]

Filed Under: Blog, Business/Financial News, News Well, Vision, Wall Street Beat Tagged With: Alcon

18 of the world’s most innovative medical technologies

April 26, 2022 By Danielle Kirsh

Judges this week are voting for the most innovative medical technologies among the nominees for the 2022 Prix Galien International Awards. The Prix Galien International Awards highlight the most innovative technologies in the life sciences industry. The New York-based Galien Foundation presents the international award to eligible nominees that have received a Prix Galien award […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Diabetes, Diagnostics, Digital Health, Endoscopic, Featured, Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Orthopedics, Patient Monitoring, Replacement Heart Valves, Stents, Structural Heart Tagged With: Abbott, Alcon, Biosense Webster, Boston Scientific, Devices4Care, Diatropix, Genmab, Germitec, Hexacath, Johnson & Johnson, Medtronic, Moveo, nanobiotix, Prix Galien International, Siemens Healthineers, sysmex, The Galien Foundation, The Hubrecht Institute, Urgo Medical, VRelax

Alcon SmartCataract study shows enhanced time savings during cataract surgery

April 25, 2022 By Sean Whooley

Alcon (NYSE:ALC) announced data from a clinical study supporting the use of its SmartCataract solutions for cataract surgery. Geneva, Switzerland-based Alcon will present the data at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting. According to a news release, Alcon’s latest data for the SmartCataract demonstrates significant time savings delivered during the […]

Filed Under: Big Data, Clinical Trials, Digital Health, Featured, Health Technology, News Well, Optical/Ophthalmic, Software / IT Tagged With: Alcon

Alcon launches new dry eye treatment device

April 8, 2022 By Sean Whooley

Alcon announced that it introduced the Systane iLux meibomian gland dysfunction (MGD) thermal pulsation system. Geneva, Switzerland-based Alcon designed the all-in-one, handheld Systane iLux MGD thermal pulsation device with new imaging technology to capture infrared photos and HD video of the meibomian glands. The system allows patients to see the need for treatment, visualize their […]

Filed Under: Business/Financial News, Featured, Imaging, News Well, Optical/Ophthalmic Tagged With: Alcon

Alcon launches Clareon intraocular lens in U.S.

March 7, 2022 By Sean Whooley

Alcon (SIX/NYSE:ALC) announced today that it launched the Clareon family of intraocular lenses (IOLs) in the U.S. Geneva, Switzerland-based Alcon designed the Clareon family of lenses with a glistening-free IOL material with the lowest levels of haze and subsurface nanoglistenings (SSNGs) compared to leading competitors’ IOLs, according to a news release. The company describes Clareon […]

Filed Under: Business/Financial News, Implants, News Well, Optical/Ophthalmic Tagged With: Alcon

Alcon stock up on Street-beating Q4

February 16, 2022 By Chris Newmarker

Alcon (SIX/NYSE:ALC) stock is up today after the eye care tech company reported fourth-quarter results that surpassed Wall Street expectations. Geneva, Switzerland–based Alcon yesterday evening reported profits of $139 million, or 28¢ per share, off $2.149 billion in sales for the quarter ended Dec. 31, 2021, for a bottom-line gain of 46% and a top-line […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Optical/Ophthalmic, Wall Street Beat Tagged With: Alcon

Alcon closes Ivantis acquisition

January 10, 2022 By Sean Whooley

Alcon (NYSE:ALC) announced today that it completed its $475 million acquisition of glaucoma surgery device maker Ivantis. Geneva, Switzerland-based Alcon initially announced the acquisition of Ivantis, which develops the Hydrus Microstent minimally invasive glaucoma surgery (MIGS) device, in November 2021. Get the full story at our sister site, Medical Tubing & Extrusion.

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Alcon, Ivantis

Alcon to acquire Ivantis for $475M

November 8, 2021 By Sean Whooley

Alcon (NYSE:ALC) announced today that it intends to acquire glaucoma surgery device maker Ivantis for $475 million upfront. Geneva, Switzerland-based Alcon aims to bolster its portfolio across cataract, refractive, retina and glaucoma offerings by acquiring Ivantis and its novel Hydrus Microstent for minimally invasive glaucoma surgery (MIGS). Ivantis designed the Hydrus Microstent to lower intraocular […]

Filed Under: Business/Financial News, Featured, Implants, Mergers & Acquisitions, Optical/Ophthalmic, Surgical, Wall Street Beat Tagged With: Alcon, Ivantis

MedTech 100 roundup: On the rise again

August 23, 2021 By Sean Whooley

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior. […]

Filed Under: Business/Financial News, Featured, Funding Roundup, MassDevice Earnings Roundup, Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Alcon, Eli Lilly, Grail, Illumina Inc., Johnson & Johnson, MedTech 100 Index, Personnel Moves, Ra Medical, stevanato group, Strata Skin Sciences, Stryker, Ultrahuman

Alcon reports 74% sales growth in Q2, raises 2021 guidance

August 18, 2021 By Danielle Kirsh

Alcon (NYSE:ALC) this week posted second-quarter results that beat the overall consensus on Wall Street and raised its full-year guidance. The Geneva-based eye care company reported profits of $151 million, or 31¢ per share, on sales of $2.1 billion for the three months ended June 30, for a sales growth of 74.79% compared with Q2 2020. […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: Alcon

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS